Literature DB >> 12517769

Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state.

I Jolanda M De Vries1, Daniëlle J E B Krooshoop, Nicole M Scharenborg, W Joost Lesterhuis, J Heleen S Diepstra, Goos N P Van Muijen, Simon P Strijk, Theo J Ruers, Otto C Boerman, Wim J G Oyen, Gosse J Adema, Cornelis J A Punt, Carl G Figdor.   

Abstract

Dendritic cells are the professional antigen-presenting cells of the immune system. To induce an effective immune response, these cells should not only express high levels of MHC and costimulatory molecules but also migrate into the lymph nodes to interact with naïve T cells. Here, we demonstrate that in vitro-generated mature, but not immature dendritic cells, efficiently migrate into the T-cell areas of lymph nodes of melanoma patients. This difference is confirmed by in vitro studies, in which immature dendritic cells are strongly adherent, whereas mature dendritic cells remain highly motile. Our present findings demonstrate that the ability of dendritic cells to mount a proper immune response correlates with their ability to migrate both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12517769

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  158 in total

Review 1.  Dendritic cell vaccines in cancer immunotherapy: from biology to translational medicine.

Authors:  Hongmei Xu; Xuetao Cao
Journal:  Front Med       Date:  2011-12       Impact factor: 4.592

2.  In vivo cellular MRI of dendritic cell migration using micrometer-sized iron oxide (MPIO) particles.

Authors:  Roja Rohani; Sonali N de Chickera; Christy Willert; Yuhua Chen; Gregory A Dekaban; Paula J Foster
Journal:  Mol Imaging Biol       Date:  2011-08       Impact factor: 3.488

3.  Labeling and Imaging of Stem Cells - Promises and Concerns.

Authors:  Richard Schäfer
Journal:  Transfus Med Hemother       Date:  2010-03-08       Impact factor: 3.747

Review 4.  Immunization delivered by lentiviral vectors for cancer and infectious diseases.

Authors:  Biliang Hu; April Tai; Pin Wang
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

Review 5.  Tolerogenic dendritic cells and their potential applications.

Authors:  Jim Hu; Yonghong Wan
Journal:  Immunology       Date:  2011-01-05       Impact factor: 7.397

6.  In vitro and in vivo imaging of initial B-T-cell interactions in the setting of B-cell based cancer immunotherapy.

Authors:  Nela Klein Gonzalez; Kerstin Wennhold; Sandra Balkow; Eisei Kondo; Birgit Bölck; Tanja Weber; Maria Garcia-Marquez; Stephan Grabbe; Wilhelm Bloch; Michael von Bergwelt-Baildon; Alexander Shimabukuro-Vornhagen
Journal:  Oncoimmunology       Date:  2015-06-17       Impact factor: 8.110

7.  The role of molecular imaging in the development of dendritic cell-based cancer vaccines.

Authors:  Giovanni Lucignani; Maria Rescigno
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

Review 8.  New routes for allergen immunotherapy.

Authors:  Pål Johansen; Seraina von Moos; Deepa Mohanan; Thomas M Kündig; Gabriela Senti
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

Review 9.  DC-based cancer vaccines.

Authors:  Eli Gilboa
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 10.  Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4.

Authors:  Pawel Kalinski
Journal:  Curr Opin Investig Drugs       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.